Inferensys

Glossary

Model Card

A structured transparency document detailing a machine learning model's intended use, evaluation results, and limitations, adapted for synthetic data generators to disclose privacy and fairness assessments.
Data scientist building training data pipeline on laptop, data preprocessing visible, technical workspace.
TRANSPARENCY DOCUMENTATION

What is a Model Card?

A model card is a structured transparency document detailing a machine learning model's intended use, evaluation results, and limitations, adapted for synthetic data generators to disclose privacy and fairness assessments.

A model card is a short, structured document accompanying a trained machine learning model that provides essential context on its intended use, performance characteristics, and known limitations. Originating from a 2019 Google research paper, it standardizes reporting across different audiences, detailing evaluation metrics disaggregated by cultural, demographic, or phenotypic factors to surface potential biases.

For synthetic data generators like GANs or VAEs, a model card extends beyond standard accuracy metrics to disclose privacy guarantees such as differential privacy parameters, membership inference attack risk scores, and fairness evaluations across generated subpopulations. It serves as a critical governance artifact for clinical data access committees, documenting the model's data provenance, ethical considerations, and out-of-scope use cases to prevent unsafe deployment.

TRANSPARENCY DOCUMENTATION

Key Features of a Model Card

A model card is a structured transparency document detailing a machine learning model's intended use, evaluation results, and limitations. For synthetic data generators, it serves as a critical governance artifact disclosing privacy guarantees, fairness assessments, and clinical plausibility metrics.

01

Intended Use and Out-of-Scope Applications

Explicitly defines the use cases for which the synthetic data generator was designed and validated, alongside explicit prohibitions against unsafe applications.

  • Intended use: Generating synthetic electronic health records for clinical trial simulation with differential privacy guarantees
  • Out-of-scope: Using generated data for direct patient care decisions without human review
  • User qualification: Specifies that only trained biostatisticians should interpret outputs
  • Includes the regulatory context (e.g., FDA SaMD classification, HIPAA Safe Harbor compliance)
18
HIPAA Identifiers Removed
ε=3.2
Privacy Budget
02

Evaluation Results and Performance Metrics

Presents quantitative benchmarks demonstrating the synthetic data's fidelity, utility, and privacy preservation using standardized metrics.

  • Statistical fidelity: Reports Frechet Inception Distance (FID) and Wasserstein distance between real and synthetic distributions
  • Downstream utility: Documents Train-Synthetic-Test-Real (TSTR) performance—models trained on synthetic data must match real-data performance within a 5% margin
  • Privacy metrics: Includes Nearest Neighbor Adversarial Accuracy (NNAA) and membership inference attack success rates
  • Clinical plausibility: Validates adherence to SNOMED CT ontologies and physiological constraints
< 5%
TSTR Performance Gap
0.51
NNAA Score
03

Training Data and Provenance

Documents the source, composition, and preprocessing of the real data used to train the generative model, enabling reproducibility and bias auditing.

  • Data sources: Specifies originating institutions (e.g., MIMIC-IV, UK Biobank) and collection timeframes
  • Demographic breakdown: Reports age, sex, race, and comorbidity distributions to surface representation gaps
  • Exclusion criteria: Lists removed subpopulations or outlier records with clinical justification
  • Preprocessing steps: Details batch effect normalization, missing data imputation strategy, and feature engineering decisions
  • Data valuation: Identifies high-value records using Data Shapley scores for targeted augmentation
MIMIC-IV
Primary Source
47k
Real Patient Records
04

Limitations, Biases, and Fairness Assessment

Candidly discloses known failure modes, representation gaps, and fairness evaluations to prevent misuse and guide responsible deployment.

  • Representation bias: Quantifies underrepresentation of rare disease cohorts or demographic minorities using statistical parity difference
  • Mode collapse: Reports whether the generator fails to produce certain clinical scenarios (e.g., rare drug interactions)
  • FairGAN constraints: Documents whether equalized odds or demographic parity constraints were enforced during training
  • Temporal drift: Warns that clinical practice changes may render synthetic data obsolete; specifies the expiration date for validity
  • Causal limitations: Clarifies that synthetic data preserves correlations but may not capture causal mechanisms without explicit causal generative modeling
0.03
Statistical Parity Diff
12 months
Validity Window
05

Ethical Considerations and Governance

Addresses the societal impact, consent frameworks, and oversight mechanisms governing the synthetic data generator's lifecycle.

  • Consent lineage: Traces whether original patients consented to derivative data generation for secondary research
  • Dual-use risk: Assesses potential for generating deepfake medical records for insurance fraud or research misconduct
  • Synthetic data watermarking: Describes embedded digital fingerprints for provenance tracking and leak detection
  • Audit trail: Specifies logging of all generation requests, including user identity, timestamp, and parameter configurations
  • Review cadence: Mandates quarterly adversarial validation checks to detect distribution shift from evolving real-world data
Quarterly
Adversarial Audit
Immutable
Audit Log
06

Technical Specifications and Model Architecture

Provides implementation details enabling independent replication, security auditing, and interoperability assessment.

  • Architecture: Specifies whether the generator uses a CTGAN, TimeGAN, WGAN-GP, or denoising diffusion probabilistic model (DDPM)
  • Differential privacy implementation: Documents the privacy accountant (e.g., Rényi DP), noise multiplier, and clipping norm
  • Hardware and runtime: Reports GPU requirements, training duration, and inference latency per 1,000 synthetic records
  • Software dependencies: Lists framework versions (e.g., Synthetic Data Vault (SDV) 1.0, PyTorch 2.0) and random seeds for reproducibility
  • Input/output schema: Defines expected feature types, categorical encodings, and output data format (e.g., FHIR R4, OMOP CDM)
CTGAN
Architecture
< 2 sec
Per 1k Records
TRANSPARENCY DOCUMENTATION

Frequently Asked Questions

Essential questions about the structure, purpose, and regulatory role of model cards in governing synthetic data generators and machine learning systems in healthcare.

A model card is a structured transparency document that details a machine learning model's intended use, evaluation results, and limitations. For synthetic data generators—such as CTGAN, TimeGAN, or Variational Autoencoders—a model card serves as a critical accountability artifact that discloses privacy guarantees, fairness assessments, and statistical fidelity metrics. Originating from Google's 2019 research paper 'Model Cards for Model Reporting,' these documents have become essential in regulated industries like healthcare, where synthetic patient data must comply with HIPAA Safe Harbor de-identification standards. A comprehensive model card for a synthetic data generator typically includes: the training data provenance and demographic composition, the generative architecture employed, Differential Privacy (DP) parameters (epsilon values), Membership Inference Attack resistance scores, Synthetic Data Quality Scores across fidelity, utility, and privacy dimensions, and explicit warnings about out-of-distribution failure modes. Regulatory bodies and clinical data access committees increasingly mandate model cards before approving synthetic datasets for secondary research use.

Prasad Kumkar

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.